Advances in Radiotherapy of Gastrointestinal Cancers

Dear Colleagues,

This Special Issue will focus on contemporary advances in radiotherapy for gastrointestinal cancers, addressing the evolving landscape of precision radiation therapy techniques, treatment optimization strategies, and personalized care approaches. Recent advances in the molecular biology of gastrointestinal cancers and technological innovations in radiation delivery, image guidance, and treatment planning have significantly enhanced therapeutic outcomes while minimizing treatment-related toxicities.

We are pleased to invite you to contribute to this Special Issue dedicated to advancing the field of radiotherapy in gastrointestinal cancer treatment.

This Special Issue will present cutting-edge research encompassing novel imaging methods, radiotherapy techniques (intensity-modulated, stereotactic, proton, and MR-guided), adaptive treatment protocols, multidisciplinary approaches, and quality-of-life considerations in gastrointestinal cancer management.

Research areas may include advanced external beam radiotherapy techniques such as intensity-modulated radiotherapy and stereotactic body radiotherapy as well as proton therapy and MR-guided therapy, innovative and adaptive radiotherapy protocols and implementation challenges, the integration of molecular imaging and radiomics into diagnostics and treatment, combination therapy strategies incorporating immunotherapy, the management and prevention of radiation toxicities, quality-of-life assessments and patient-reported outcome measures, cost-effectiveness analyses of modern radiotherapy techniques, artificial intelligence applications in treatment planning and delivery, and multidisciplinary care coordination in gastrointestinal cancer management.

We welcome original research articles, systematic reviews, and comprehensive analyses that can help to advance our understanding of optimal radiotherapy in gastrointestinal malignancies.

Prof. Dr. Sunil Krishnan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.